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Rcccivcd 1 July I992 
The acquired resistance to various drugs in ctnccr is mcdiatcd by P&%oprolcin (Pmyp) which is cncadcd by the mdr.l gcoc, An incrcascd level 
of mdb 1Ip.g~ was dcmonstrutcd after chcmolhcrapy adminirtcrcd IQ lrcitf cancer in humans. To clarify the direct cllkc~ of antiunccr drugs on 
mdr.l/P-gp cxprcuion. WC invcstigatcd the change in transport of adriamycin (ADR), and the cxprcssion of the mdr-I pnc and P-gp in an 
ADR.trcatcd, multidrug+csistant lcukcmic cell line (K562/ADR& The addition of ADR induced Ihc ovcr.cxpr&on of mdr.l/k-gp, which &d 
to a transient decrease in the intracellular accumulation of ADR although the diffcrcnsc was not statistically rigniftcant. A maximal cffcct WUL 
observed uncr 4 h incubation, returning to the barrlinc lcvcl after further incubation for I 2ra24 h. The phosphorylatiun of Pnpp was inversely 
corrclatcd with ilrc lcvcls of P.gp, That observations suggest hat ADR itself modulates both thc c..prcuion and funslion of Psgp. Drlerminalion 
of I~C optimul sthrdulc for adminirwring adrianrycin is cssenrirl IO rchicving the oprimal cll’cct In trcnllny cancer. 
Multidrug rcsirumcc; mdpl: P.glycoprotein; Adrinmycin 
1. INTRODUCTION 
Many cell lines sclcctcd for rcsirtrrncc in vitro to one 
unticllnscr drug also show cros+r&tnncc to other 
ugcnts which arc structurally and functionally unrelated 
[I,?]. Most of thcsc ccl1 lines overexpress the m&-l 
gene and its product, P-g:ycoprotcin (P-gp) [3-61. P-gp 
is thought to function 8s an ATP-dependent drug cfflux 
pump [4,§]. The promotl:r egion of the mdr-1 gcnc wus 
rcccntly isolated [7,8]. The regulatory mechanism of the 
expression of this gcnc has been studied in normal and 
malignant cells. Such stimuli as heat shock and diffcrcn- 
tiating agents have been s~town to modify its expression 
of the mdr-1 gcnc [9-121, 
The dcvclopmcnt of mltltidrug esistancc is a major 
clinical problem in the chcmothcrapy of cancer. The 
incrcascd expression of mdr=l/P-gp has been dcmon- 
stratcd following chcmothcrapy [13,14]. However. the 
level of mdr-1 mRNA and P-gp does not always result 
from gene amplification [i&16]. To clarify the mccha- 
nism involved, WC investigated the direct cfl&ts of adri- 
amycin (ADR) on the expression of mdr-l/P-gp and 
intxxcllular drug accumulation by using a multidrug 
resistant cell line which was trcatcd with ADR for var- 
ying periods of time. 
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2. EXPERIMENTAL 
1. I. MuIrrids 
hdriamycin (ADR) was kindly providsd by Kyowu Hnkko Kogyo 
Co. flokyo. Japan). [‘:?]Protcin A (1,11 GBcQml) and [‘:Pbrtho- 
phonphalc (370 MBq/ml) wcrc from tCN Biomedical Inc. (Costa 
Mesa. CA). Iy.‘V]ATP (370 MOq/ml) and [a-“P)dcTP(370 MBqlml) 
wcrc obtained rrom Amsrshum (Buckingbrmshirc, UK). Moneclonsl 
atrlibody against P.glycoprotcin (Pa@ was from Ccntosorc (BaIti- 
more. MD) [171. The olignnuclcotidr prok specific for mdr.1 gcnc, 
GTTCAAACT’TCXGCTCCTG (scsiducs 2734-2752, antiscnr 
strand) wus prrprrcd on an Applied Diosystcnt 391 uutomatcd synthc- 
rizcr. The actin probe was purchased from Cormo Bio Co, (Tokyo, 
Japan). Protein A-Scpharosc C4.8 was obtained from tiilarmacis 
LKD (Uppsalu. Swcdcn), 
711~ multi-drug rtiistunt sublinc. K56YADR* was dcvclopcd in 
vitro in our laboratory from the human myclogenous cell lint, KS62. 
and maintuincd with 500 nM of ADR [ 181, The cells wcrc cultured in 
an ADR.frcc medium for 3 days before thcsc cxpcrimcnrr. The cells 
wcrc incubated in RPM1 l&IO containing 10% of fetal calf strum 
(FCS) with 2yM of ADR for 0,4.8, I2 and 24 h in 5% COJ-95% air 
at 37.C. They wcrc used in the following cxpcrimcntr aflcr washing 
with cold phosphate-buffcrcd sulinc (PBS). The viability of the cells 
was maintained above 90% during each Lrcalmcnt psriod. 
The intracellular accumulation of ADR in cells incubated with lhis 
agent for spcciricd intervals was determined by rcsurpcnding the cslls 
(5 x IOVml) in frtih medium with 2pM of ADR at 37.C for 60 min. 
The cells wcrc washed twice with cold PBS containing 1% bovine 
serum albumin (BSA). and Ihcn extracted wilh 0.3 N MCI-SOB ctha- 
nol. The concentration of ininccllutr ADR was dctcctcd by SPCC_ 
trofluoromctry (Shimadzu RF 5000) al an cxciulion wavclcngth of 
470 nm and emission wnvclcngth of 585 nm. 
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The mcmhnnc fruction of ccllr trcrfcd with ADR for spseificd 
intcrvuls wnr prcpurcd by the method or Bcllr et al. [ 19). The mcm- 
bmnc frxtion (1rM kc*\ Y’W qr.Wcd nn R% SDS-PAGE and ~rxx- 
fcrrcd onla u nitroccllulusc turcr (Schfck~cr & SL+IU&, Dil$;rsir(, (Jdr- 
many). The filler was preincubrlcd overnight &II 4’C with blockiny 
b&x (3% BSA in Triebull’crcd arlinc) und fhcn incubated with I 
/#ml monoclonul nntibocly. C219. in blocking buffer ror 3 :. :t room 
rcmpcruturc. The filter was washed with 0.2% NPAO in Trir-buffcrcd 
nlinc, und incubated with [‘:‘llprolcin A 91 37 KBqlml in blocking 
bufl2r for 1 h. After cxtcnsivc washing, the fiber wus uuloradiogrs- 
phcd with an inlcnrifyiny screen ut -7O’C. 
Total RNA was extracted by Iysis in guunidinc rhiocysnulc and 
ccnW’ugutiun in u ccsium chloride gradient. Total RNA (10~~) ww 
clcclrophorcred on 1% ugurouc yeis after &ax;rluian. mw&rrcrt 
onto nylon mcmbmncs (Biodync 8, Pall, East Hill& NY) und hybrid- 
ized with on m&l oligonuclcolidc pro& 5’ end lnbclcd wiih [r- 
‘:P]ATP und polynuclcotidc kiniuc. The nylon mcmbranc wus rc- 
hybridized with un [a~~~P~dCTP~Iub&d uclin probe. Autorudiogruphy 
WI curried OUI with un inlcnsifying scram HI -7O*C, 
After incubation with ADR for spscificd intervals. K562/ADRI, 
ccllr (I x IO’) wcrc suspended in phosphas.frcc Hnnk’r bulnnccd wit 
solution (HUSS) containing IO% of diulyzed FCS. And metabolically 
lubclcd with [‘:P]orthophosp!Uc (9?,5 MDqlml) fo: 4 h at 37’C. The 
cells were wurhsd three times with 0, IS M NnCI. 10 mM Trir-HCl, ~1% 
7.4, and roluhilizcd in cold lysis buffer (0.15 M NxCi, 50 mM Trir- 
MCI. I% Tritan X-100. I% dcoxgcholutc, 0.1% SDS. 1 mM EGTA. 
2 mM MnCI:, I mM phcnylmclhylrulfonyl fluoride) an ice lor 30 min. 
The coil lysatc~ wcrc chriflcd by ecntrirugution OI 10.000 XR for 5 min 
and incuba\cd with normal mouse strum for 30 min nnd then wilh 
protein A-Scphurosc for 30 min, und the beads wcrc removed. Im- 
munoprccipitalion WUK carried out wilh C219 antibody (I &ml) for 
? h al 4’C and immune complcxcs wcrc collcctcd on protein A- 
Scphurosc C&B by I h incubation at 4*C. The bsudr wcrc ccnlrifugcd 
und washed three timer wiih Iysir buffer. once with 0.5 M NaCI. IO 
mM TrieHCI, pH 7.4,0.1% Triton X-LOO und once withO. IS M N&I. 
IO mM TrireHCI. pH 7.4. Finally, lhc protein brrund IO bsadr Will 
solubili;rcd in 2% SDS, 2% 2acrcaptocrhnnol. 10% plyccrol and 6X5 
mM Trir.HCI, pH 6.8. boiled for 3 min and rcpurrlcd on 8% SDS- 
PAGE, followed by eutorndiogruphy, 
3. RESULTS 
Fi& IA shows the change in the intracclluior OCCU~U- 
lation of ADR after incubation with 2 ,uM of ADR, a 
concentration which is about twice the I& for ADR in 
K562’ADR,00 [IS], for spccificd intervals. The average 
intrxellular ascumulotion of ADR in three expcrimcnts 
decreased transiently in the cells treated with ADR over 
4-8 h, and recovered to the initial level in the cells 
treated for 24 h, A maximal inhibition of 60% of the 
initial lcvcl was observed at 8 h incubation. Hawcver, 
the difference was not significant because of the wide 
variation in bass! values between experiments. 
To clarify the mechanism for the change in ADR 
uptake, WC studied the level of P-gp in the cells treated 
with ADR by Western blotting using C219 monoclonal 
antibody. The amount OF P-gp increased by about 20% 
after incubation for 4 h, and reverted to the initial lcvcl 
after incubation for 8 h. Furthermore, it was down. 
0 4 8 12 24 
Time coyrae (hr) 
Fig. I. lntruccllul~r xtxmulntion of ADR uficr incubation wirh 2pM 
of ADR for rp&icd limes nnd rcsurpcndcd with fresh medium con* 
taining 2 PM of ADR, nnd inrubatcd Tar 60 min. The data wcrc un 
nvcralpc (1S.D,) of three cxprinlcntr. 
regulated utter incubation for 12-24 h (Fig. 2). WC then 
examined mdr-1 ycnc expression by Northern blotting 
using the mdr-1 specific probe. The expression of the 
mdr-1 gcnc was nlso induced transiently in the cells 
treated with ADR for 4 h, and was then suppressed to 
the initinl level (Fig. 3) These observations confirmed 
that the suppression of intraccllulur accumulation of 
ADK nftcr exposure to ADR was due to the ovcr-cx- 
pression of mdr- I/P-gp. 
The phosphoryletion of P-gp was cnhonccd after 
ADR trcrrtmcnt for 12-24 h (Fig, 4). while the amount 
of P-gp was decreased uring tkcsc incubation periods. 
as shown in Fig. 2, 
4. DISCUSSION 
WC observed that an rrntictlnccr drug, ADR. itself 
induced an over-expression of mdr-l/P-gp. with a dc- 
srcasc in the intruscllular accumulation of this drug in 
multidrug-resistant ccl1 lines. The expression of the 
mdr-1 gene appears to bc corrclatcd with the copy num- 
ber of the gcns in most multidrug resistant cell lines [6], 
but revertants of thcsc cell lines were usually chrtractcr- 
izcd by :! decreased expression of this gene without a 
loss of amplified DNA [ 151. In cancer patients, the mdr- 
1 gene is frequently expressed after chemotherapy and 
is not always amplified [20]. Our results support the 
previous findings that the cxprcssion of mdr-1 gene may 
bc transcriptionally regulated by anticancer drugs 191. 
This phenomenon may be one of the mechanisms for 
protecting the cell against an anticonccr drug by prc- 
176 
Volume 308, number 2 FEDS LEITERS Aupt 1992 
0 4 8 12 24 
\ / 
K562 K562~AlX~ 
Fig. 3. Northern blot mrlysh of m&-l gcnc cxprcssian. Equal 
mmounts of lotttl RNA <lOj~g) wcrc npplid to cash LMC and probttd 
with the mdr- I prolx (ugpcr) orj&tin prolx (lower). The first lane 
rhowr II s;lmplc or ADR-scnuitivc KS62 ccllli ussd tts Y nqtttivc con- 
trol. 
vious studies hkvc shown that the level of mdr-l@gp 
expression that was induced by differentiating agents. 
and sustained throughout cxposurc, dccrcascd rapidly 
wit11 n half life of several hours after removal of the 
ugcnts. returning to basclinc in about 12 h [ll]. In this 
study, the ovcrexprcssion of the mdr-1 gene was tran- 
sicnt. but continuous ADR trcatmcnt returned it to the 
initial Icvcl. Differentiation inducers and anticancer 
drugs rnny rcgulrrtc the cxprcssion differently. It is also 
possible thnt newly expressed P-gp dccrcnsrs the intra- 
ccllulur ADR lcvcl as u function of drug cfFlux pump, 
and thus, the effect is trunsirnt, 
serving LI low lcvcl of intraccllul;lr drug conccntr~tion. We showed that the lcvcl of P-gp phosphorylation 
Howcvcr. the precise mechanism by which ADK modu- 
lates mdr-1 gcnc expression is unknown. Some form of 
stress, including differentiating agents or heat shock. 
tire known to induce mdr-1 gene expression (10-I 21. The 
promoter scqucncc of the mdr-1 gene has been idcnti- 
ficd [7]. Kollno et al. [9] rcportcd thnt the mdr-1 pro- 
moter was activated by anticancer drugs, including vin- 
cristinc. drrunomycin, ond colchicinc. by using a tran- I. 
sient CAT expression assay. Raymond and Gros [8] 
*. 
demonstrated the cell-specific activity of c&acting regu- 
latory elements in the promoter of the mdr-1 gcnc. 
Thcsc findings support he idea that rrrrtts-acting rcguln- 
tory factors arc constitutivcly or inducibly expressed in 
both normal cells rnd malignant cells, 
0 4 8 12 24 48hra 
Fig. 2. Wcrtom blotting nnttlysis of P-glycoprotcin. 100 j&g of mcm- 
brttnc protein was npplicd tocuch lane, scpttntcd on 8% SDS-PAGE. 
ttnd probed with monuslon~tl vntibody CZIS). 
We observed that the effect of ADR on the expression 
of mdr-l/P-gp appeared rclativcly early, within 4-8 h, 
and diminished after prolonged incubation with ADR. 
The cxprcssion of mdr-1 mRNA was also inducible by 
another anticancer drug, uctinomycin D, in rcvcrtant 
cell lines after re-exposure to the drug (211. Thcsc au- 
thors found that mdr-1 mRNA expression was en= 
hanccd following prolonged incubation 172 h) with the 
drug. Their USC of rcvcrtant cells may explain the differ- 
cnce in time-course as compared with our findings. Prc- 
0 4 12 a4 48 hrs 
Fig. 4. Phosphorylalion of P-glycoprotcin after trcatmcnt with ADR. 
CCIIJ were labeled with [‘zP]orthophosphatc. Thephnspk@tcd pr@ 
tcin WIJ immunoprccipitatcd usingC219 monoclonal onlihody. Sam- 
plcs wcrc ana:jzcd OIL 8% SDS-PAGE. 
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induscd by ADR was invcrsly corrclatcd with the level 
of P-gp, Rcccnt studies have dcmonstmtcd thut phos- 
phorylution plays an impartnnt role in the biological 
activity of P-gp [ 22-24]. The activation of protein kinssc 
C by phorbol esters inducco drug rcsistuncc [?S], while 
an inhibitor of this kinasc. staurosporinc. inhibits P-gp 
phosphoryltltion and lco+ IO SL concomitant increase in 
drug accumulation as a r,sult of the inhibition of cfflux. 
Calcium channel blockers und calmodulin inhibitors 
[23,26,27], inhibitors of active drug cfflux. lcod to tin 
increase in P-gp phosphorylution. Thcsc results arc con- 
trovcrsinl in relation to phosphorylacion and function 
of P-gp. although phorbol :sters nnd calcium channel 
Uockcrs arc thought to induce phosphoryhtion at dif- 
fcrcnt sites of the protein [26]. Although the mrxlro- 
nisms by which ADR induces phosphorylntion of P-gp 
during prolonged incubation ir; not known. it is likely 
that the phosphorylation by ADR also modifies the 
function of this protein. 
In conclusion, exposure to ADR modified the cxprcs- 
sion of mdr-l/P-gp in o timc-dcpcndcnt m;Inncr. Clnrih- 
cution of the prcciss mcchnnism will help to avoid drug 
rcsistancc and uid the efficient udministrntion of chcmo- 
therapy to cunccr prrticnts. 
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